From:
`To:
`Cc:
`
`Subject:
`Date:
`
`Trials
`Elizabeth.Holland@allenovery.com; Trials
`Elizabeth.Weiswasser@weil.com; anish.desai@weil.com; robert.vlasis@weil.com; Natalie.Kennedy@weil.com;
`Andrew.Gesior@weil.com; Regeneron.IPR.Service@weil.com; Christopher.Pepe@weil.com;
`NMitrokostas@goodwinlaw.com; NovartisPFS@AllenOvery.com
`RE: IPR2021-00816 – Request for conference call [AO-NYO1.0066057.0000134.FID531109]
`Tuesday, May 17, 2022 5:14:27 PM
`
`Counsel: A conference call has been schedule for tomorrow, May 18, at 2:00 PM ET. The dial-in
`information is below:
`
`877-720-9361
`
`Passcode 6792673#
`
`Thank you,
`
`Maria King
`Deputy Chief Clerk for Trials
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`703-756-1288
`
`From: Elizabeth.Holland@allenovery.com <Elizabeth.Holland@allenovery.com>
`Sent: Monday, May 16, 2022 4:43 PM
`To: Trials <Trials@USPTO.GOV>
`Cc: Elizabeth.Weiswasser@weil.com; anish.desai@weil.com; robert.vlasis@weil.com;
`Natalie.Kennedy@weil.com; Andrew.Gesior@weil.com; Regeneron.IPR.Service@weil.com;
`Christopher.Pepe@weil.com; NMitrokostas@goodwinlaw.com; NovartisPFS@AllenOvery.com
`Subject: IPR2021-00816 – Request for conference call [AO-NYO1.0066057.0000134.FID531109]
`
`CAUTION: This email has originated from a source outside of USPTO. PLEASE CONSIDER THE SOURCE before
`responding, clicking on links, or opening attachments.
`
`Your Honors,
`
`I write to respectfully request a conference call with the Board to seek permission for Patent Owner to file
`a surreply declaration responding to the following paragraphs in the declarations submitted by Petitioner
`together with its Reply:
`
`Reply Declaration of Horst Koller (Ex. 1105) ¶¶ 23, 28-29, 54-55, 63-64, 112-113 and 122
`Declaration of Dr. Kenneth S. Graham (Ex. 1102 ) ¶¶ 14-29
`Declaration of Joel M. Cohen (Ex. 1108) ¶¶ 31-34
`
`The basis for Patent Owner’s request is that these paragraphs contain new arguments and/or evidence.
` Petitioner opposes Patent Owner’s request.
`
`The parties are available for a conference call tomorrow, Tuesday May 17, between 10 am and 11 am
`EDT and Wednesday May 18 after 2 pm EDT.
`
`IPR2021-00816
`Ex. 3002
`
`

`

`Respectfully submitted,
`
`Elizabeth Holland
`Lead Counsel for Patent Owner
`
`Elizabeth Holland | Partner
`Allen & Overy LLP
`1221 Avenue of the Americas
`New York, New York 10020
`
`Office: +1 212 610 6365
`Mobile: +1 917 420 3743
`
`www.allenovery.com
`
`This email is confidential and may also be privileged. If you are not the intended recipient please delete it and notify
`us immediately by telephoning or e-mailing the sender. You should not copy it or use it for any purpose nor disclose
`its contents to any other person.
`
`Allen & Overy LLP
`1221 Avenue of the Americas
`New York, New York 10020
`Tel: 212 610 6300
`Fax: 212 610 6399
`http://www.allenovery.com
`
`Allen & Overy LLP is a limited liability partnership registered in England and Wales with registered number
`OC306763 and SRA number 401323. It is authorized and regulated by the Solicitors Regulation Authority of
`England and Wales. Allen & Overy LLP is a multi-jurisdictional law firm with lawyers admitted to practice in a
`variety of jurisdictions.
`The term partner is used to refer to a member of Allen & Overy LLP or an employee or consultant with equivalent
`standing and qualifications. A list of the members of Allen & Overy LLP and of the non-members who are
`designated as partners is open to inspection at its registered office, One Bishops Square London E1 6AD and at the
`above address.
`
`For further information about how Allen & Overy LLP is regulated, please see our website at
`www.allenovery.com/en-gb/global/legal-notices.
`
`Our privacy policy is available at https://www.allenovery.com/en-gb/global/legal-notices/privacy-policy
`
`